Armed with $137M fund, Signet launches hunt for a dozen new biotech plays
Signet Healthcare Partners is getting the year started by rolling out a new, $137 million biotech fund.
The New York-based group won’t win any …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
